This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Microvesicles provide a mechanism for intercellular communication by embryonic stem cells during embryo implantation.
Nat Commun. 2016 Jun 15;7:11958. doi: 10.1038/ncomms11958.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.
COG0153175 / 6 / 169
Galactokinase (EC 2.7.1.6) (Galactose kinase)Q9R0N0Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.
COG0153175 / 6 / 169
[1]